Lindsay M. Morton
Division of Cancer Epidemiology and Genetics
National Cancer Institute
National Institutes of Health
Department of Health and Human Services
USA
Name/email consistency: high
- Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. Morton, L.M., Curtis, R.E., Linet, M.S., Bluhm, E.C., Tucker, M.A., Caporaso, N., Ries, L.A., Fraumeni, J.F. J. Clin. Oncol. (2010)
- Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Morton, L.M., Purdue, M.P., Zheng, T., Wang, S.S., Armstrong, B., Zhang, Y., Menashe, I., Chatterjee, N., Davis, S., Lan, Q., Vajdic, C.M., Severson, R.K., Holford, T.R., Kricker, A., Cerhan, J.R., Leaderer, B., Grulich, A., Yeager, M., Cozen, W., Hoar Zahm, S., Chanock, S.J., Rothman, N., Hartge, P. Cancer Epidemiol. Biomarkers Prev. (2009)
- Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort. Morton, L.M., Wang, S.S., Richesson, D.A., Schatzkin, A., Hollenbeck, A.R., Lacey, J.V. Int. J. Cancer (2009)
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Morton, L.M., Wang, S.S., Cozen, W., Linet, M.S., Chatterjee, N., Davis, S., Severson, R.K., Colt, J.S., Vasef, M.A., Rothman, N., Blair, A., Bernstein, L., Cross, A.J., De Roos, A.J., Engels, E.A., Hein, D.W., Hill, D.A., Kelemen, L.E., Lim, U., Lynch, C.F., Schenk, M., Wacholder, S., Ward, M.H., Hoar Zahm, S., Chanock, S.J., Cerhan, J.R., Hartge, P. Blood (2008)
- Encouraging participation in medical research: what strategies work?. Morton, L.M. J. Clin. Epidemiol (2008)
- Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Morton, L.M., Landgren, O., Chatterjee, N., Castenson, D., Parsons, R., Hoover, R.N., Engels, E.A. Blood (2007)
- Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Morton, L.M., Bernstein, L., Wang, S.S., Hein, D.W., Rothman, N., Colt, J.S., Davis, S., Cerhan, J.R., Severson, R.K., Welch, R., Hartge, P., Zahm, S.H. Carcinogenesis (2007)
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Morton, L.M., Turner, J.J., Cerhan, J.R., Linet, M.S., Treseler, P.A., Clarke, C.A., Jack, A., Cozen, W., Maynadié, M., Spinelli, J.J., Costantini, A.S., Rüdiger, T., Scarpa, A., Zheng, T., Weisenburger, D.D. Blood (2007)
- DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Morton, L.M., Wang, S.S., Bergen, A.W., Chatterjee, N., Kvale, P., Welch, R., Yeager, M., Hayes, R.B., Chanock, S.J., Caporaso, N.E. Pharmacogenet. Genomics (2006)
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D., Linet, M.S. Blood (2006)
- Reporting participation in epidemiologic studies: a survey of practice. Morton, L.M., Cahill, J., Hartge, P. Am. J. Epidemiol. (2006)
- Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Morton, L.M., Schenk, M., Hein, D.W., Davis, S., Zahm, S.H., Cozen, W., Cerhan, J.R., Hartge, P., Welch, R., Chanock, S.J., Rothman, N., Wang, S.S. Pharmacogenet. Genomics (2006)
- Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Morton, L.M., Hartge, P., Holford, T.R., Holly, E.A., Chiu, B.C., Vineis, P., Stagnaro, E., Willett, E.V., Franceschi, S., La Vecchia, C., Hughes, A.M., Cozen, W., Davis, S., Severson, R.K., Bernstein, L., Mayne, S.T., Dee, F.R., Cerhan, J.R., Zheng, T. Cancer Epidemiol. Biomarkers Prev. (2005)